We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

GN Tobacco Use Survey

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00121368
First Posted: July 21, 2005
Last Update Posted: November 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
Global Network for Women's and Children's Health Research
Bill and Melinda Gates Foundation
John E. Fogarty International Center (FIC)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Dental and Craniofacial Research (NIDCR)
RTI International
Information provided by (Responsible Party):
NICHD Global Network for Women's and Children's Health
July 15, 2005
July 21, 2005
November 25, 2013
February 2004
May 2005   (Final data collection date for primary outcome measure)
Tobacco use [ Time Frame: Cross sectional ]
Not Provided
Complete list of historical versions of study NCT00121368 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
GN Tobacco Use Survey
Survey on Tobacco Use in the GN Sites
Smoking can contribute to many health problems for mothers and their babies. In developing countries, there is little information about the number of pregnant women that smoke and the reasons why some pregnant women choose to smoke. The purpose of this multi-site tobacco use survey is to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.

Smoking is regarded as one of the few potentially preventable factors associated with low birth weight, very preterm birth and perinatal death. In an effort to determine the prevalence of tobacco use (smoking and smokeless tobacco) and to collect relevant data in support of a potential smoking prevention or cessation intervention, a multi-site tobacco use survey is being conducted in several countries. The survey will be used to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.

The primary outcome is tobacco use status during pregnancy. Secondary outcomes include: knowledge and attitudes regarding tobacco products, health hazards of tobacco use and environmental tobacco smoke (ETS) exposure.

Sample size of 750 per country was calculated under the assumptions that the prevalence of tobacco use could be as low as 0.05 with a coefficient of variation of approximately 15% and a prevalence of 0.10 with a CV of approximately 11%.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Pregnant women 18-45
Smoking
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
6000
May 2005
May 2005   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pregnant women of legal consent and child-bearing age (18-45)
  • Attendance at a participating clinic

Exclusion Criteria:

  • Pregnant women with disabilities such as deafness, serious mental illness, or mental retardation
Sexes Eligible for Study: Female
18 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Argentina,   Brazil,   Congo,   Ecuador,   Guatemala,   India,   Pakistan,   Zambia
 
 
NCT00121368
CP01 Tobacco Use
Yes
Not Provided
Not Provided
NICHD Global Network for Women's and Children's Health
NICHD Global Network for Women's and Children's Health
  • National Cancer Institute (NCI)
  • Global Network for Women's and Children's Health Research
  • Bill and Melinda Gates Foundation
  • John E. Fogarty International Center (FIC)
  • National Center for Complementary and Integrative Health (NCCIH)
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • RTI International
Principal Investigator: Michele Bloch, MD, PhD National Cancer Institute (NCI)
NICHD Global Network for Women's and Children's Health
November 2013